NASDAQ:OMCL Omnicell Q3 2026 Earnings Report $33.60 +0.16 (+0.48%) Closing price 10/2/2026 04:00 PM EasternExtended Trading$33.59 -0.01 (-0.03%) As of 10/2/2026 07:32 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. ProfileEarnings HistoryForecast Omnicell EPS ResultsActual EPSN/AConsensus EPS $0.42Beat/MissN/AOne Year Ago EPSN/AOmnicell Revenue ResultsActual RevenueN/AExpected Revenue$304.43 millionBeat/MissN/AYoY Revenue GrowthN/AOmnicell Announcement DetailsQuarterQ3 2026Date10/29/2026TimeBefore Market OpensConference Call DateThursday, October 29, 2026Conference Call Time8:30AM ETConference Call ResourcesEarnings HistoryCompany Profile Omnicell Earnings HeadlinesQ2 earnings highlights: Tandem Diabetes (NASDAQ:TNDM) vs the rest of the healthcare technology stocksSeptember 30 at 9:50 AM | msn.comOmnicell (OMCL) Stock Trades Below Fair Value After A 78% SlumpSeptember 22, 2026 | uk.finance.yahoo.comThe end may be near for these iconic stocksMarc Chaikin, founder of Chaikin Analytics, says two forces - AI disruption and fracturing global trade - are triggering a historic wealth transfer already underway in 2026. Household names like Intuit (-57%), Boston Scientific (-49%), and Tractor Supply (-40%) are cratering, while lesser-known companies like Sandisk (+573%) and Rackspace (+444%) surge. Chaikin has identified specific stocks he believes investors should sell before they fall further - and the names may surprise you. He's also pinpointing a company tapped as Nvidia's self-driving partner and a potential AI megadeal that could split into three high-growth stocks. Stream his free presentation to get every buy and sell recommendation with no membership or credit card required.October 3 at 1:00 AM | Chaikin Analytics (Ad)3 reasons OMCL is risky and 1 stock to buy insteadSeptember 21, 2026 | msn.com1 cash-heavy stock to target this week and 2 we questionSeptember 11, 2026 | msn.comTraceLink, Omnicell Integrate DSCSA Compliance Into Hospital Pharmacy WorkflowsSeptember 3, 2026 | rttnews.comSee More Omnicell Headlines Get Earnings Announcements in your inboxWant to stay updated on the latest earnings announcements and upcoming reports for companies like Omnicell? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Omnicell and other key companies, straight to your email. Email Address About OmnicellOmnicell (NASDAQ:OMCL) provides medication-management technology and related services for health care providers. Its solutions are designed to help hospitals, health systems, retail pharmacies and other care settings manage medication inventory, improve workflow efficiency and support medication adherence. The company’s offerings include automated medication dispensing systems, central pharmacy automation, medication packaging and adherence solutions, pharmacy inventory management tools, and software for medication-use analytics and workflow management. Omnicell also provides implementation, maintenance, consulting and other support services associated with its technology platforms. Founded in 1992 and headquartered in Mountain View, California, Omnicell serves customers primarily in the United States, as well as in international markets. Its products are used across hospitals, health-system pharmacies, long-term care facilities, specialty pharmacies and other health care environments.View Omnicell ProfileRead more More Earnings Resources from MarketBeat Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Latest Articles MarketBeat Week in Review – 09/28 - 10/02Time to Nibble on MCD Stock After it Enters Oversold Territory?McCormick Stock Trades Cheap, Offers Dividend Growth and Unilever Deal UpsideMicron’s Earnings Reveal Why the AI Memory Boom May Last LongerAnthropic's IPO Could Put Amazon's and Alphabet's Paper Profits to the TestBoeing’s Fighter Victory Opens the Door to Decades of Defense RevenueCorning and AT&T's $3 Billion Fiber Deal Reveals Where AI Spending Goes Next Upcoming Earnings PepsiCo (10/8/2026)Delta Air Lines (10/9/2026)America Movil (10/13/2026)Citigroup (10/13/2026)The Goldman Sachs Group (10/13/2026)JPMorgan Chase & Co. (10/13/2026)Wells Fargo & Company (10/13/2026)Johnson & Johnson (10/13/2026)UnitedHealth Group (10/13/2026)Bank of America (10/14/2026) Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.